Cargando…
Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236566/ https://www.ncbi.nlm.nih.gov/pubmed/35483383 http://dx.doi.org/10.1016/S1470-2045(22)00203-0 |
| _version_ | 1784736560970727424 |
|---|---|
| author | Oosting, Sjoukje F van der Veldt, Astrid A M Fehrmann, Rudolf S N GeurtsvanKessel, Corine H van Binnendijk, Rob S Dingemans, Anne-Marie C Smit, Egbert F Hiltermann, T Jeroen N den Hartog, Gerco Jalving, Mathilda Westphal, Tatjana T Bhattacharya, Arkajyoti de Wilt, Faye Boerma, Annemarie van Zijl, Lisanne Rimmelzwaan, Guus F Kvistborg, Pia van Els, Cecile A C M Rots, Nynke Y van Baarle, Debbie Haanen, John B A G de Vries, Elisabeth G E |
| author_facet | Oosting, Sjoukje F van der Veldt, Astrid A M Fehrmann, Rudolf S N GeurtsvanKessel, Corine H van Binnendijk, Rob S Dingemans, Anne-Marie C Smit, Egbert F Hiltermann, T Jeroen N den Hartog, Gerco Jalving, Mathilda Westphal, Tatjana T Bhattacharya, Arkajyoti de Wilt, Faye Boerma, Annemarie van Zijl, Lisanne Rimmelzwaan, Guus F Kvistborg, Pia van Els, Cecile A C M Rots, Nynke Y van Baarle, Debbie Haanen, John B A G de Vries, Elisabeth G E |
| author_sort | Oosting, Sjoukje F |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9236566 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-92365662022-06-28 Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours Oosting, Sjoukje F van der Veldt, Astrid A M Fehrmann, Rudolf S N GeurtsvanKessel, Corine H van Binnendijk, Rob S Dingemans, Anne-Marie C Smit, Egbert F Hiltermann, T Jeroen N den Hartog, Gerco Jalving, Mathilda Westphal, Tatjana T Bhattacharya, Arkajyoti de Wilt, Faye Boerma, Annemarie van Zijl, Lisanne Rimmelzwaan, Guus F Kvistborg, Pia van Els, Cecile A C M Rots, Nynke Y van Baarle, Debbie Haanen, John B A G de Vries, Elisabeth G E Lancet Oncol Comment Elsevier Ltd. 2022-07 2022-04-25 /pmc/articles/PMC9236566/ /pubmed/35483383 http://dx.doi.org/10.1016/S1470-2045(22)00203-0 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Comment Oosting, Sjoukje F van der Veldt, Astrid A M Fehrmann, Rudolf S N GeurtsvanKessel, Corine H van Binnendijk, Rob S Dingemans, Anne-Marie C Smit, Egbert F Hiltermann, T Jeroen N den Hartog, Gerco Jalving, Mathilda Westphal, Tatjana T Bhattacharya, Arkajyoti de Wilt, Faye Boerma, Annemarie van Zijl, Lisanne Rimmelzwaan, Guus F Kvistborg, Pia van Els, Cecile A C M Rots, Nynke Y van Baarle, Debbie Haanen, John B A G de Vries, Elisabeth G E Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours |
| title | Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours |
| title_full | Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours |
| title_fullStr | Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours |
| title_full_unstemmed | Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours |
| title_short | Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours |
| title_sort | immunogenicity after second and third mrna-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours |
| topic | Comment |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236566/ https://www.ncbi.nlm.nih.gov/pubmed/35483383 http://dx.doi.org/10.1016/S1470-2045(22)00203-0 |
| work_keys_str_mv | AT oostingsjoukjef immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT vanderveldtastridam immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT fehrmannrudolfsn immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT geurtsvankesselcorineh immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT vanbinnendijkrobs immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT dingemansannemariec immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT smitegbertf immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT hiltermanntjeroenn immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT denhartoggerco immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT jalvingmathilda immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT westphaltatjanat immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT bhattacharyaarkajyoti immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT dewiltfaye immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT boermaannemarie immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT vanzijllisanne immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT rimmelzwaanguusf immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT kvistborgpia immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT vanelscecileacm immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT rotsnynkey immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT vanbaarledebbie immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT haanenjohnbag immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours AT devrieselisabethge immunogenicityaftersecondandthirdmrna1273vaccinationdosesinpatientsreceivingchemotherapyimmunotherapyorbothforsolidtumours |